Hit enter to search or ESC to close
Once energized by the “drill, baby, drill” rallying cry of former U.S. President Donald Trump, the oil and gas sector may no longer be booming, but it’s far from obsolete. That’s the message from...
With a share price rally of 42.8% year-to-date, ST Engineering (SGX:S63) is now the Straits Times Index’s top performer. Behind the gains is a story of strategic transformation, smart positioning amid global defence rearmament,...
Two of Asia’s leading property trusts—Frasers Centrepoint Trust (FCT) and CapitaLand India Trust (CLINT)—are making bold strategic plays to shape the future of retail and digital infrastructure across the region. While FCT is betting...
In a tale of two electric vehicle (EV) giants, Tesla and BYD are locked in a global battle for dominance — and while Ark Invest’s Cathie Wood remains staunchly bullish on Tesla’s future, China’s...
The FTSE REIT Index is testing a well-established resistance at 633, and momentum may finally be tilting toward a breakout. Analysts note that both short- and medium-term indicators have strengthened, but caution that the...
Hongkong Land (HKL) has made a landmark commitment to China, unveiling West Bund Central in Shanghai — the group’s largest single investment to date, valued at US$11.5 billion. While HKL has traditionally been associated...
Lim Seong Hai Capital Berhad (LSH Capital) IPO Purpose of IPO: LSH Capital aims to raise RM168.08 million through its IPO to fund business expansion, repay bank borrowings, and for working capital. The...
Visen Pharmaceuticals, a biopharmaceutical company specializing in endocrinology treatments in China, is set to list on the Hong Kong Stock Exchange under the ticker 02561.HK. The IPO is scheduled for March 21, 2025, aiming...
Value Partners is making a compelling argument for why quality China A-shares may present significant upside potential, citing two major factors: deep undervaluation and Beijing’s push for a “value-up” strategy. The firm’s proprietary Free...
Johor Bahru could soon rival Kuala Lumpur and Penang as a major medical hub, as healthcare players, including Thomson Medical Group, eye the Johor-Singapore Special Economic Zone (JS-SEZ) for expansion. Thomson Medical, controlled by...
